We report three patients who had serious disturbance of anticoagulant control while receiving ifosfamide/mesna-containing cytotoxic chemotherapy in association with warfarin. In view of the likely biological potentiation of warfarin by ifosfamide/mesna, close monitoring of anticoagulant control should be performed during the co-administration of these drugs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2429713 | PMC |
http://dx.doi.org/10.1136/pgmj.66.780.860 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!